Strategies for Prevention of Neonatal Invasive Candidiasis

Seminars in Perinatology

Volumn 27, Issue 5, 2003, Pages 414-424

  Kaufman, David ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LIPID; MICONAZOLE; NYSTATIN; STEROID;

ABDOMINAL SURGERY; CANDIDIASIS; CENTRAL VENOUS CATHETER; DERMATITIS; DRUG ABSORPTION; DRUG ACTIVITY; DRUG EXCRETION; DRUG METABOLISM; ENDOTRACHEAL TUBE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; MORBIDITY; MORTALITY; NECROTIZING ENTEROCOLITIS; NEWBORN; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN DISEASE;

EID: 0242298307     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-0005(03)00067-3     Document Type: Article

References (65)

1. Stoll BJ, Hansen N, Fanaroff AA, et al: Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291, 2002
2. Saiman L, Ludington E, Pfaller M, et al: Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect. Dis. J 19:319-324, 2000
3. Saiman L, Ludington E, Dawson JD, et al: Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 20:1119-1124, 2001
4. Karlowicz MG, Hashimoto LN, Kelly RE, Jr et al: Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 106:E63, 2000
5. Chapman RL, Faix RG: Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J 19:822-827, 2000
6. Noyola DE, Fernandez M, Moylett EH, et al: Ophthalmologic, visceral, and cardiac involvement in neonates with candidemia. Clin Infect Dis 32:1018-1023, 2001
7. EORTC International Antimicrobial Therapy Cooperative Group: Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 86:668-672, 1989
8. Rex JH, Walsh TJ, Sobel JD, et al: Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect. Dis 30:662-678, 2000
9. Marr KA, Seidel K, Slavin MA, et al: Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 96:2055-2061, 2000
10. Rotstein C, Bow EJ, Laverdiere M, et al: Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. Clin Infect. Dis 28:331-340, 1999
11. Goodman JL, Winston DJ, Greenfield RA, et al: A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845-851, 1992
12. Waggoner-Fountain LA, Walker MW, Hollis RJ, et al: Vertical and horizontal transmission of unique Candida species to premature newborns. Clin Infect. Dis 22:803-808, 1996
13. Huang YC, Lin TY, Leu HS, et al: Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: Clinical implications and genotyping analysis. Infection 27:97-102, 1999
14. Reef SE, Lasker BA, Butcher DS, et al: Nonperinatal nosocomial transmission of Candida albicans in a neonatal intensive care unit: Prospective study. J Clin Microbiol 36:1255-1259, 1998
15. Gillespie HL IWSV: Incidence of Candida in the vagina during pregnancy. Obstet Gynecol 16:185-188, 1960
16. Gugnani HC, Nzelibe FK, Gini PC, et al: Incidence of yeasts in pregnant and non-pregnant women in Nigeria. Mycoses 32:131-135, 1989
17. Maudsley RF, Brix GA, Hinton NA, et al: Placental inflammation and infection. A prospective bacteriologic and histologic study. Am J Obstet. Gynecol 95:648-659, 1966
18. Pfaller MA: Epidemiology and control of fungal infections. Clin Infect Dis 19suppl 1:S8-13, 1994
19. Huang YC, Li CC, Lin TY, et al: Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect. Dis J 17:819-822, 1998
20. Silverman J, Vazquez JA, Sobel JD, et al: Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species. Infect. Control Hosp. Epidemiol 20:676-684, 1999
21. Damjanovic V, Connolly CM, van Saene HK, et al: Selective decontamination with nystatin for control of a Candida outbreak in a neonatal intensive care unit. J Hosp Infect 24:245-259, 1993
22. Burnie JP: Candida and hands. J Hosp Infect 8:1-4, 1986
23. Larson E, Silberger M, Jakob K, et al: Assessment of alternative hand hygiene regimens to improve skin health among neonatal intensive care unit nurses. Heart Lung 29:136-142, 2000
24. Boyce JM, Pittet D: Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect. Control 30:S1-46, 2002
25. Yamaki K, Thorlacius H, Xie X, et al: Characteristics of histamine-induced leukocyte rolling in the undisturbed microcirculation of the rat mesentary. Br J Pharmacol 123:340-399, 1998
26. Botas CM, Kurlat I, Young SM, et al: Disseminated candidal infections and intravenous hydrocortisone in preterm infants. Pediatrics 95:883-887, 1995
27. Pera A, Byun A, Gribar S, et al: Dexamethasone therapy and Candida sepsis in neonates less than 1250 grams. J Perinatol 22:204-208, 2002
28. Mittal M, Dhanireddy R, Higgins RD: Candida sepsis and association with retinopathy of prematurity. Pediatrics 101:654-657, 1998
29. Malloy PJ, Zhao X, Madani ND, et al: Cloning and expression of the gene from Candida albicans that encodes a high-affinity corticosteroid-binding protein. Proc Natl Acad Sci USA 90:1902-1906, 1993
30. Campbell JR, Zaccaria E, Baker CJ: Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: A case-control study. Pediatrics 105:1041-1045, 2000
31. Oski K, Pappagallo M, Lerer T, et al: Does Aquaphor in Extremely Low Birth Weight Infants Increase the Risk for Nosocomial Sepsis. Pediatr Res 49:227A(abstr), 2001
32. Schanler RJ: The use of human milk for premature infants. Pediatr Clin North Am 48:207-219, 2001
33. Hylander MA, Strobino DM, Dhanireddy R: Human milk feedings and infection among very low birth weight infants. Pediatrics 102:38, 1998
34. Fanaroff AA, Korones SB, Wright LL, et al: A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 330:1107-1113, 1994
35. Cairo MS, Agosti J, Ellis R, et al: A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates. J Pediatr 134:64-70, 1999
36. Rowen JL, Rench MA, Kozinetz CA, et al: Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr 124:789-794, 1994
37. Baley JE, Kliegman RM, Boxerbaum B, et al: Fungal colonization in the very low birth weight infant. Pediatrics 78:225-232, 1986
38. Hageman JR, Stenske J, Keuler H, et al: Candida colonization and infection in Very Low Birth Weight Infants. J Perinatol 6:251-254, 1985
39. Kicklighter SD, Springer SC, Cox T, et al: Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 107:293-298, 2001
40. Pappu-Katikaneni LD, Rao KP, Banister E: Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 33:20-23, 1990
41. Sims ME, Yoo Y, You H, et al: Prophylactic oral nystatin and fungal infections in very-low- birthweight infants. Am J Perinatol 5:33-36, 1988
42. Leibovitz E, Iuster-Reicher A, Amitai M, et al: Systemic candidal infections associated with use of peripheral venous catheters in neonates: A 9-year experience. Clin Infect. Dis 14:485-491, 1992
43. Weitkamp JH, Poets CF, Sievers R, et al: Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome). Infection 26:11-15, 1998
44. El Masry FA, Neal TJ, Subhedar NV: Risk factors for invasive fungal infection in neonates. Acta Paediatr 91: 198-202, 2002
45. Gotzsche PC, Johansen HK: Nystatin prophylaxis and treatment in severely immunodepressed patients. The Cochrane Library. 1. 2003. Update Software, Oxford
46. Hofstra W, Vries-Hospers HG, van der WD: Concentrations of nystatin in faeces after oral administration of various doses of nystatin. Infection 7:166-170, 1979
47. Wainer S, Cooper PA, Funk E, et al: Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection. Pediatr Infect. Dis J 11:713-716, 1992
48. Kaufman D, Boyle R, Hazen KC, et al: Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345:1660-1666, 2001
49. Huang YC, Li CC, Lin TY, et al: Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect. Dis J 17:819-822, 1998
50. Million L, Manteaux A, Reboux G, et al: Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: Persistence of Candida albicans strains with the same genotype. J Clin Microbiol 32:1115-1118, 1994
51. Saxen H, Hoppu K, Pohjavuori M: Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Clin Pharmacol. Ther 54:269-277, 1993
52. McGuire W, Clerihew L, Austin N: Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. [Systematic Review]. The Cochrane Library 1. 2003. Update Software, Oxford.
53. Pfaller MA, Messer SA, Hollis RJ, et al: Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 33:217-222, 1999
54. Pfaller MA, Diekema DJ, Jones RN, et al: Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J Clin Microbiol 40:852-856, 2002
55. Marr KA, Seidel K, White TC, et al: Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 181:309-316, 2000
56. Rowen JL, Tate JM, Nordoff N, et al: Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol 37: 3735-3737, 1999
57. Huang YC, Kao HT, Lin TY, et al: Antifungal susceptibility testing and the correlation with clinical outcome in neonatal candidemia. Am J Perinatol 18:141-146, 2001
58. White TC: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother 41:1482-1487, 1997
59. Kaufman D, Boyle R, Robinson M, et al: Long-Term Safety of Intravenous Prophylactic Fluconazole use in preterm infants less than 1000 grams. Pediatr Res 53: 484A(abstr), 2002
60. Karlowicz MG, Rowen JL, Barnes-Eley ML, et al: The role of birth weight and gestational age in distinguishing extremely low birth weight infants at high risk of developing candidemia from infants at low risk: A multicenter study. Pediatr Res 51:301A(abstr), 2002
61. Faix RG, Kovarik SM, Shaw TR, et al: Mucocutaneous Mucocutaneotis and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 83:101-107, 1989
62. Darmstadt GL, Dinulos JG, Miller Z: Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics 105:438-444, 2000
63. Rowen JL, Atkins JT, Levy ML, et al: Invasive fungal dermatitis in the < or = 1000-gram neonate. Pediatrics 95:682-687, 1995
64. Baley JE, Silverman RA: Systemic candidiasis: Cutaneous manifestations in low birth weight infants. Pediatrics 82:211-215, 1988
65. Benjamin DK Jr, Ross K, McKinney RE Jr, et al: When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics 106:712-718, 2000